Gene · 2906
Papers1,100
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,100
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Corrigendum to "CircBIRC6 facilitates the malignant progression via miR-488/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer" [Pharmacol. Res. 202 (2024) 107127]. | Pharmacol Res | 2026 | 42805841 | PubTator, text mining | PubMed |
| Construction of molecular signatures based on the co-expression network of NECSO-related gene TRPM4 and its prognostic value in hepatocellular carcinoma. | J Gastrointest Oncol | 2026 | 42703320 | PubTator, text mining | PubMed |
| GRIN-related epilepsy in Chinese pediatric patients: a retrospective study of clinical, genetic, and mutant protein structural features in a tertiary center cohort. | World J Pediatr | 2026 | 42681313 | PubTator, text mining | PubMed |
| DNA Methylation at Core N-Methyl-D-Aspartate (NMDA) Receptor Genes Reveals a Glutamatergic Signature of Aging in Post-COVID Whole Blood With Implications for Long-COVID Neuropsychiatric Sequelae. | Cureus | 2026 | 42471918 | PubTator, text mining | PubMed |
| GluN2D-containing NMDA receptors support dentate granule cell excitability, synaptic plasticity, and memory. | bioRxiv | 2026 | 42427625 | PubTator, text mining | PubMed |
| NMDA Receptor-Targeted Neuroprotection in Ischemic Stroke: The 3S Framework Integrating Spatiotemporal Dynamics, Subtype Selectivity, and Signaling Pathways. | Curr Neuropharmacol | 2026 | 42337875 | PubTator, text mining | PubMed |
| Expression and Localization of NMDA Receptor GluN2 Subunits in Dorsal Horn Pain Circuits across Sex, Species, and Late Postnatal Development. | J Neurosci | 2026 | 42167918 | PubTator, text mining | PubMed |
| Association Between GRIN1 rs28489906 and Major Depressive Disorder and Treatment Response to Antidepressants in Patients with Type 2 Diabetes. | Brain Sci | 2026 | 41892611 | PubTator, text mining | PubMed |
| Paradoxical Expression of Ionotropic Glutamate Receptors in Leucocytes. | Clin Rev Allergy Immunol | 2026 | 41854785 | PubTator, text mining | PubMed |
| GluN2D NMDA Receptors: Bridging Physiology and Pathology. | Biol Psychiatry | 2026 | 41765344 | PubTator, text mining | PubMed |
| Multi-ancestry genome-wide association study and meta-analysis of lung function decline. | Respir Res | 2026 | 41764487 | PubTator, text mining | PubMed |
| Molecular Profiling of Polish Pediatric Patients with Epilepsy: A Single-Center Diagnostic Experience Using Next-Generation Sequencing. | Genes (Basel) | 2026 | 41751517 | PubTator, text mining | PubMed |
| GRIN2D-Related Developmental and Epileptic Encephalopathy Associated With Polymorphic Seizures Including Epileptic Spasms. | Int J Dev Neurosci | 2026 | 41673952 | PubTator, text mining | PubMed |
| Promotion of lung cancer growth via glutamate ionotropic receptor N-methyl-D-aspartate-type subunit 2D (GRIN2D). | J Thorac Dis | 2026 | 41660435 | PubTator, text mining | PubMed |
| Multiple sclerosis burden and quality of care index in China and the G20 (1990-2021): A cross-regional analysis using global burden of disease database 2021. | Medicine (Baltimore) | 2026 | 41578531 | PubTator, text mining | PubMed |
Modulating tonic NMDA receptor currents: mechanistic insights into ketamine, esketamine, and dextromethorphan for major depressive disorder and implications for the discovery and development of investigational agents. | Expert Opin Ther Targets | 2026 | 41577431 | PubTator, text mining | PubMed |
| Integrated bioinformatics and experimental validation identify FOXQ1, GRIN2D, and SCNN1B as novel biomarkers for distinguishing high-risk sessile serrated lesions from hyperplastic polyps. | J Mol Histol | 2026 | 41546794 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic changes associated with lead exposure in spermatozoa. | Asian J Androl | 2026 | 41527937 | PubTator, text mining | PubMed |
| The positive allosteric modulator GNE-9278 increases gating, conductance, and Ca2+ permeability for GluN2D-containing NMDA receptors. | Neuropsychopharmacology | 2026 | 41501539 | PubTator, text mining | PubMed |
| Memantine treatment in individuals with GRIN gain-of-function variants is associated with improvements in behavior, development, and seizure frequency. | Epilepsia | 2026 | 41489401 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2906/papers